Codexis (CDXS) Net Margin (2010 - 2026)

Codexis (CDXS) recorded quarterly Net Margin of 57.08% in Q1 2026, down 331.37% quarter-over-quarter from 24.67% in Q4 2025, and up 21718.0% on a YoY basis from N/an in Q1 2025.

Codexis (CDXS) Net Margin (2010 - 2026) Analysis & Trends

Codexis' Net Margin history runs 17 years deep, the most recent figure standing at 57.08% for Q1 2026.

  • In Q1 2026, Net Margin rose 21718.0% year-over-year to 57.08%; the TTM figure through Mar 2026 stood at 40.96% (up 10851.0% YoY), while the FY2025 annual figure was 62.47%, up 4752.0% from the prior year.
  • Net Margin was 57.08% for Q1 2026 at Codexis, down from 24.67% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 24.67% in Q4 2025 to a low of 376.29% in Q3 2023.
  • Historically, Net Margin has averaged 131.24% across 5 years, with a median of 86.59% in 2025.
  • The sharpest annual moves came in 2023 and 2026: Net Margin slumped 34730 bps in 2023, then jumped 21718 bps in 2026.
  • A 5-year view of Net Margin shows it stood at 63.66% in 2022, then plunged by 126 bps to 143.84% in 2023, then jumped by 66 bps to 48.35% in 2024, then jumped by 151 bps to 24.67% in 2025, then plunged by 331 bps to 57.08% in 2026.
  • The last three Net Margin figures came in at 57.08% (Q1 2026), 24.67% (Q4 2025), and 228.05% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 0.82%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 34.53%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn -57.08%

Historic Data

Download Data
DateValue
Mar 31, 2026 -57.08%
Dec 31, 2025 24.67%
Sep 30, 2025 -228.05%
Jun 30, 2025 -86.59%
Mar 31, 2025 -274.27%
Dec 31, 2024 -48.35%
Sep 30, 2024 -160.84%
Jun 30, 2024 -285.19%
Mar 31, 2024 -67.39%
Dec 31, 2023 -143.84%
Sep 30, 2023 -376.29%
Jun 30, 2023 -230.46%
Mar 31, 2023 -174.22%
Dec 31, 2022 -63.66%
Sep 30, 2022 -28.99%
Jun 30, 2022 -6.87%
Mar 31, 2022 -23.64%
Dec 31, 2021 -41.59%
Sep 30, 2021 6.10%
Jun 30, 2021 -16.76%